Home-delivered, medically tailored meals may benefit recently hospitalized patients with heart failure
A new Kaiser Permanente study finds promise in ‘food as medicine’ delivery for some — but not all — patients with chronic conditions.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Not all adults newly diagnosed with diabetes equally likely to start treatment
Kaiser Permanente study found adults of certain racial and ethnic groups are less likely to start medication within the first year of diagnosis.
New clues in early prediction of gestational diabetes
Kaiser Permanente researchers have identified several biological markers in the blood of pregnant people that are tied to an increased risk of developing gestational diabetes later in pregnancy.
No difference found in infant outcomes between glyburide and insulin for gestational diabetes
A study of 11,321 patients treated for gestational diabetes with insulin or the medication glyburide did not find a difference in cesarean section rates or outcomes for the patients’ infants, suggesting many people with gestational diabetes could forego insulin injections in favor of taking a pill.
Shining a light on early-onset type 2 diabetes
To mark National Diabetes Month, KP Research Radio spoke with research scientist Anjali Gopalan, MD, MS, about the unique needs of young people with diabetes or prediabetes.
Continuous glucose monitors help patients manage type 2 diabetes
New Kaiser Permanente study finds continuous glucose monitors are associated with improved blood sugar control and fewer visits to the emergency room for hypoglycemia in type 2 diabetes patients treated with insulin.
Longtime women’s health study SWAN tackles the challenges of aging
A long-term study that has produced important insights into menopause and women’s health at midlife is starting its 27th year with new federal funding from the National Institute on Aging (NIA) at 7 sites including the Kaiser Permanente Division of Research in Oakland.
Pandemic increased mail order pharmacy use by people with diabetes, but racial disparities persist
Kaiser Permanente study finds less use among Black, Hispanic, and Hawaiian/Pacific Islander patients compared to white and Asian patients.
$5.6 million awarded to Kaiser Permanente researcher to study treatments for type 2 diabetes
A research team led by Romain S. Neugebauer, PhD, received the award from the Patient-Centered Outcomes Research Institute to compare costs, and benefits and harms of second-line medications.
Gestational diabetes can be tip-off to future increased risk for heart disease
Kaiser Permanente research shows 2-fold higher risk for heart artery calcification after pregnancy through mid-life, even in women with normal blood sugar levels.
